Create an Account

Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice

Meeting report with video, highlights and slides of PACE-CME symposium held at EuroPrevent 2018 in Ljubljana. More to be added soon

Episodes 1-3 of 3

  • Diabetes How to reduce risk from a cardiovascular perspectiveDiabetes How to reduce risk from a cardiovascular perspective
    Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice
    Diabetes: How to reduce risk from a cardiovascular perspective?
    • Prof. Diederick Grobbee
      Prof. Diederick Grobbee

      Prof. Diederick Grobbee

  • Practical management of cardiovascular risk Lessons from latest diabetes trialsPractical management of cardiovascular risk Lessons from latest diabetes trials
    Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice
    Practical management of cardiovascular risk: Lessons from latest diabetes trials
    • Prof. Lars Rydén
      Prof. Lars Rydén

      Prof. Lars Rydén

  • The cardiovascular challenge for primary care in diabetesThe cardiovascular challenge for primary care in diabetes
    Preventing CVD in Patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice
    The cardiovascular challenge for primary care in diabetes
    • Prof. Richard Hobbs, MD
      Prof. Richard Hobbs, MD

      Prof. Richard Hobbs, MD

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.